ITM to Host Symposium on Actinium-225 Targeted Radionuclide

ITM to Host Symposium on Actinium-225 Targeted Radionuclide Therapy and to Present Phase III COMPOSE Trial Design at the Theranostics World Congress

ITM to Host Symposium on Actinium-225 Targeted Radionuclide Therapy and to Present Phase III COMPOSE Trial Design at the Theranostics World Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , Wiesbaden , Hessen , Garching , Bayern , Munich , Communicationsjulia Hofmann Susanne Karlsson , Neil Quigley , Methodsneil Quigley , Steffen Schuster , Sebastian Marx , Udoj Vetter , Matthias Eiber , Clinic For Nuclear Medicine , University Hospital Essen , Technical University Of Munich , Garching Munichdistrict Court , Symposium Program , Deutsche Bank Freiburg , Theranostics World Congress , Polyclinic For Nuclear Medicine , Wall Street , Technologies Munich , Targeted Alpha Therapies , Radionuclide Therapy , Current Perspective , Associate Professor , Nuclear Medicine , Preclinical Theranostics , Global Product Manager , Targeted Radionuclide Therapy , Radiomolecular Precision Oncology , Global Perspective , Future Outlookssaturday , Production Methodsneil Quigley , Prostate Cancer , University Hospital , Clinical Experience , Technical University , Communicationsjulia Hofmann , Susanne Karlsson Phone , Relationsben Orzelek Phone , Klaus Maleck , Munichdistrict Court , Tax Number ,